Company Profile
Andros Pharmaceuticals Co.,Ltd, a biopharmaceutical company develops novel drug delivery platform technologies. The company develops APC101, a fast-drying, film-forming, and meter-dosed spray, which is in Phase IIa clinical trial to treat pain associated with post-herpetic neuralgia.
Its portfolio also includes APC201, a novel dosage form of topical anesthetic that is in Phase I/II clinical trial for treatment of Osteoarthritis, and siRNA, an anti-sense oligonucleotide and DNA candidate.
Its preclinical phase products are APC310 and APC501 for anesthesia to intravenous catheter placement and venipuncture APC401, a special emulsified solution for anesthesia of post-surgery pain.
Founded in 2008, The company offers LALP cream for dermal analgesic applications. Its portfolio also includes iMinos solution for Alopecia Androgenetica, and T4 endonuclease V. Andros Pharmaceuticals is based in Zhubei, Taiwan.